AGENDA
All sessions listed in Eastern time. Agenda subject to change.
ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!
This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Clinical trial data evaluating targeted therapies for patients with non-small cell lung cancer (NSCLC)
- Greater competence related to
- Utilizing diagnostic methodologies to identify molecular alterations in patients with NSCLC
- Personalizing therapy for patients with NSCLC and molecular alterations
- Mitigating trAEs in patients receiving targeted therapy for NSCLC
- Greater confidence in their ability to communicate treatment considerations with patients with NSCLC and molecular alterations as a member of the interprofessional team
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding
- the Clinical trial data evaluating targeted therapies for patients with NSCLC and resistance to therapy
- Greater competence related to
- Personalizing therapy for patients with NSCLC and certain molecular alterations
- The use of systemic therapy in patients with advanced NSCLC with CNS metastases
- Greater confidence in their ability to communicate treatment considerations with patients with NSCLC and molecular alterations as a member of the interprofessional team
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Clinical trial data evaluating immunotherapy as treatment for patients with NSCLC
- Greater competence related to
- Selecting the most appropriate immunotherapy-containing regimen for a patient with NSCLC
- Managing immune-related adverse events in patients receiving immunotherapy for NSCLC
- Greater confidence in their ability to
- Communicate treatment considerations with the interprofessional team
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Clinical trial data evaluating regimens used to treat patients with SCLC
- Evidence for radiation therapy in the management of patients with SCLC
- Greater competence related to
- Identifying potential treatment-related adverse events in patients receiving therapy for SCLC
- Greater confidence in their ability to
- Leverage the use of the multidisciplinary team to optimize outcomes in patients with SCLC
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Clinical trial data evaluating immunotherapy strategies for patients with mesothelioma
- Clinical trial data investigating emerging targeted therapeutic strategies
- Greater confidence in their ability to
- Effectively communicate aspects of care with mesothelioma patients as a part of the multidisciplinary team
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Rationale for systemic therapy in patients with early-stage and locally advanced NSCLC
- Complimentary roles of surgery, radiotherapy, and systemic therapy in early-stage and locally advanced NSCLC
- Key data from clinical trials evaluating systemic treatment in patients with early-stage and locally advanced NSCLC
- Greater confidence in their ability to
- Collaborate as a member of the interprofessional team to manage patients with early-stage and locally advanced NSCLC
MODERATOR
Learning Objectives
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Importance of early lung cancer detection and screening
- Clinical trial data evaluating screening and early detection methods
- Greater confidence in
- Their ability to incorporate strategies into clinical practice that may improve early detection of lung cancer as a member of the interprofessional team
- Their ability to identify optimal approaches to patient care
MODERATOR